February 14, 2022
The Healthcare Technology Report is pleased to announce The Top 25 Biotech CEOs of 2022. Over the past year, these leading biotechnology executives and their organizations have demonstrated ingenuity, skill, and perseverance in solving tremendous challenges. The specialties of this year’s CEOs and their companies run the gamut from gene therapy to vaccine development, cancer treatment, proteomics, mRNA-based therapeutics, and much more. Many of the awardees have also found success in raising significant amounts of funding for their companies, which enables them to continue to have positive impact on the biotechnology field for years to come.
One achievement all of our honorees share is the notable contributions they have made towards advancing the biotechnology industry. From hundreds of nominees, these executives stood out for their unflagging commitment to improving lives through the advancement of medicine. Please join us in recognizing the accomplishments of The Top 25 Biotech CEOs of 2022. Read rest here.
John Vitalie, Aizon
Title: Chief Executive Officer
John Vitalie serves as Chief Executive Officer and Board Member for Aizon, an AI software provider that transforms manufacturing operations with the use of advanced analytics, artificial intelligence, and other smart factory technologies focused on optimizing production and quality within highly regulated industries. Vitalie joined Aizon in March 2020, shortly after the Series B funding round was closed, and brings tremendous experience in sales leadership and accelerated growth to propel the company into this new phase.
Previously, Vitalie served as Senior Vice President of NAA CX Sales for Oracle, where he led Oracle’s front office application sales and drove several key CX categories while also driving higher growth. Before Oracle, Vitalie led the entire go-to-market organization as the Senior Vice President of the Healthcare and Life Sciences vertical for North America at Salesforce, Inc. He comes from a strong corporate leadership background, including serving as CEO of Precise Software, President and CEO of Encover, Inc., and Corporate Vice President for NASDAQ Stock Exchange. He also established Siebel Systems as the global market leader of the Life Science Industry as VP of Sales. John received his MBA from the Stanford Graduate School of Business and a Bachelor of Science from the Business School Honors Program at the Indiana University of Pennsylvania.